Últimas noticias sobre Helius Medical Tech (NASDAQ:HSDT) Bolsa

Helius Medical Tech

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ANAB

ASST

CCLD

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

DWTX

HSDT

HUBC

LSTA

NEHC

NFLX

SEPN

STFS

USEG

Netflix sorprende con un aumento en suscriptores y mejores pronósticos. Descubre también los mayores ganadores y perdedores del premercado.

Acciones de Netflix se disparan alrededor del 15%; 20 acciones que se están moviendo en el premercado de EE.UU.

APLD

AZTR

CRKN

CVGW

GCTK

GLAC

LFWD

MASS

ORKA

QBTS

QUBT

RIME

SGBX

VMAR

VRME

Descubre las acciones ganadoras y perdedoras en el premercado, con Vision Marine liderando un aumento del 45%.

Las acciones de Vision Marine (VMAR) se disparan un 45%; 20 acciones que se están moviendo en premercado

AMPG

AVGR

BIPC

CHEK

CREV

FDSB

KORE

LAES

LIND

NCRA

NEUE

NVNI

RELI

SLGL

TIVC

TLRY

TOVX

Carbon Revolution lidera con un aumento del 62,4% en el premercado. ¿Qué otras acciones destacaron antes de la apertura?

Las acciones de Carbon Revolution (CREV) están subiendo un 62%; 20 acciones que se están moviendo en el premercado

Helius Medical Technologies, Inc. - Class A Common Stock

Helius Medical Technologies Inc

Helius Medical Technologies Inc Warrants (02/02/2026)

JP Morgan analyst Samik Chatterjee maintains Keysight Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEYS#NYSE">KEYS</a>) with a Overweight and lowers the price target from $200 to $172.

Price Target

Analyst Ratings

KEYS

JP Morgan Maintains Overweight on Keysight Techs, Lowers Price Target to $172

Stifel analyst Tore Svanberg maintains Credo Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>) with a Buy and lowers the price target from $85 to $69.

CRDO

Stifel Maintains Buy on Credo Technology Group, Lowers Price Target to $69

JP Morgan analyst Samik Chatterjee maintains Jamf Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAMF#NASDAQ">JAMF</a>) with a Overweight and lowers the price target from $18 to $15.

JAMF

JP Morgan Maintains Overweight on Jamf Holding, Lowers Price Target to $15

JP Morgan analyst Samik Chatterjee maintains Jabil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBL#NYSE">JBL</a>) with a Overweight and lowers the price target from $175 to $154.

JP Morgan Maintains Overweight on Jabil, Lowers Price Target to $154

BREA, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- via IBN -- <a href="https://www.globenewswire.com/Tracker?data=_yuXVQ1jmKzlU2M07o5I-KA0oKKBejKbY0alkS7vhMvbJ2KeaL0aZ22gVrpflvQrAlvRnfc-gUNV6KYIH25Q0YpEy2A3aXyqXj9ZT_MUnKGavddeHr-yNxtlLZQsOuep-NeuQGyxdNVEVnUiQx0I9za0ulJyjvlCXTR3nU-1f00wImMt04oKkpQCqk-U32VD39gCHMa92rZ9DzwK5SkFq3ibIacGzSi_rfMgDk_6-mRyAugBRzaTeqMNMpEjzvx2F6chXEdCNbuR8RVyIK-Kxw==">Mullen Automotive, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) ("Mullen" or the "Company"), an electric vehicle ("EV") manufacturer, announces its subsidiary, Bollinger Motors, has delivered the first 2025 Bollinger B4 truck of multiple orders to EnviroCharge for conversion into a mobile charging unit.
Bollinger B4 trucks will be upfitted with custom EV Level 3, 120 kilowatt-charging units by EnviroCharge, a service-disabled veteran-owned, charge point operating company (CPO), based in Indiana.
The first Bollinger B4 upfitted truck is planned to debut at the Advanced Clean Trucking (ACT) Expo 2025 in Anaheim, California, on April 28 – May 1. Additional trucks will be deployed in California, providing reliable mobile charging solutions to meet the growing demand for EV infrastructure.
Bollinger Motors has qualified for multiple federal and state incentive programs, including:
<ul>
<li>Inflation Reduction Act incentives of up to $40,000 per vehicle.</li>
<li>California: Innovative Small e-Fleet (ISEF) Pilot Program, with incentives up to $120,000 per vehicle.</li>
<li>Massachusetts: voucher of up to $30,000 per vehicle from Massachusetts Offers Rebates for Electric Vehicles (MOR-EV).</li>
<li>New York: up to $100,000 from NYTVIP through NYSERDA.</li>
<li>Pennsylvania: up to a $20,000 grant from Alternative Fuels Incentive Grant Program (AFIG) of the Pennsylvania Department of Environmental Protection.</li>
</ul>

MULN

Mullen Automotive's Bollinger Motors Delivers First 2025 Bollinger B4 Truck Of Multiple Orders To EnviroCharge For Conversion Into Mobile Charging Unit

Stifel analyst Tore Svanberg maintains Cirrus Logic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRUS#NASDAQ">CRUS</a>) with a Buy and lowers the price target from $140 to $112.

CRUS

Stifel Maintains Buy on Cirrus Logic, Lowers Price Target to $112

JP Morgan analyst Joseph Cardoso maintains Insight Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSIT#NASDAQ">NSIT</a>) with a Neutral and lowers the price target from $193 to $156.

NSIT

JP Morgan Maintains Neutral on Insight Enterprises, Lowers Price Target to $156

Stifel analyst Tore Svanberg maintains Ambarella (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMBA#NASDAQ">AMBA</a>) with a Buy and lowers the price target from $100 to $80.

AMBA

Stifel Maintains Buy on Ambarella, Lowers Price Target to $80

JP Morgan analyst Samik Chatterjee maintains Ingram Micro Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGM#NYSE">INGM</a>) with a Neutral and lowers the price target from $26 to $20.

INGM

JP Morgan Maintains Neutral on Ingram Micro Holding, Lowers Price Target to $20

Process optimization enhances data acquisition and processing speed, lowers reagent costs, and maintains test performance for early lung cancer detection.
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fbioaffinitytech.com%2F&amp;esheet=54239434&amp;newsitemid=20250417360177&amp;lan=en-US&amp;anchor=bioAffinity+Technologies%2C+Inc.&amp;index=1&amp;md5=6cf1c0460c4a9b3308ae303e35610d3b">bioAffinity Technologies, Inc.</a> (NASDAQ:<a href="https://www.benzinga.com/stock/BIAF#NASDAQ">BIAF</a>, BIAFW)), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer, today announced implementation of key efficiency measures for its flagship product, <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.cypathlung.com&amp;esheet=54239434&amp;newsitemid=20250417360177&amp;lan=en-US&amp;anchor=CyPath%26%23174%3B+Lung&amp;index=2&amp;md5=44c7bdf0780f49405bb7bf9938620e26">CyPath&#xAE; Lung</a>, the Company's noninvasive test for detection of lung cancer. These improvements are projected to decrease the time required to acquire sample data for analysis by nearly 50% and reduce the cost of sample processing by approximately 60%.
The recent enhancements streamline lab processing and data acquisition workflows, reduce reagent usage, and cut laboratory supply costs—all without changing the test itself, how patient sputum samples are collected and processed, or the method by which data is acquired and analyzed. The improvements are expected to result in a greater than 10% increase in overall throughput and a greater than 25% decrease in unit cost.

BIAF

BioAffinity Technologies Implements Key Efficiency Measures For Its Flagship Product, CyPath Lung, Noninvasive Test For Detection Of Lung Cancer

Nissan Motor is making bold moves in the world of autonomous driving. The automaker <a href="https://wayve.ai/press/nissan-announcement/">announced</a> it is partnering with London-based AI startup Wayve Technologies to power the next generation of its ProPilot driver-assist system, set to debut in vehicles by the 2027 fiscal year.&nbsp;
This partnership marks the first time a global carmaker plans to embed Wayve's advanced <a href="https://www.benzinga.com/news/management/25/04/44746436/amazon-ceo-justifies-large-ai-investments-as-once-in-a-lifetime-reinvention-of-everything-we-know">AI</a> directly into production vehicles. Wayve, backed by a staggering $1.3 billion in <a href="https://www.benzinga.com/news/24/07/39792802/openai-backed-startup-anysphere-raises-400m-in-new-funding-round">funding</a> led by SoftBank, has scrambled into the ranks of serious players in the autonomous vehicle space. Other major investors include Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), and Uber (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>).
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li>Invest in the future of digital engagement: <a href="https://www.benzinga.com/money/vatom-adv">Own a piece of the $100 billion Metaverse for just $500</a>.</li>
</ul>
<h2 class="wp-block-heading">Nissan&#8217;s Bold Step Toward Human-Like AI Driving</h2>
Launched with a mission to bring "embodied intelligence" to mobility, Wayve's AI is built to navigate the complexities of real-world driving environments in a dynamic, human-like manner. Traditional autonomous systems are heavily dependent on high-definition maps and a suite of sensors, but Wayve applies camera-based learning to adjust to dynamic environments.
Wayve co-founder and CEO Alex Kendall shared the company's vision, <a href="https://evmagazine.com/news/how-nvidia-backed-wayve-disrupts-auto-tech-with-ai-solutions">telling EVMagazine.com</a>, &#8220;At Wayve, our vision is to develop autonomous technology that not only becomes a reality in millions of vehicles but also earns people's trust by seamlessly integrating into their everyday lives to unlock extraordinary value.&#8221;
Wayve's technology has already seen a fair amount of test effort. The startup's AI software has been put through its paces using Ford Mustang Mach-E and Jaguar I-Pace electric sport utility vehicles throughout the UK, the U.S., and Germany. Partnering with Uber, Wayve is also working on an eventual rollout of fully autonomous vehicles through the ride-hailing giant's platform.
Trending: With shares starting at $1.52, <a href="https://www.benzinga.com/money/how-a-10k-bet-on-health-care-originals-could-have-skyrocketed-your-portfolio">this could be your chance to invest in the future of healthcare</a>.
<h2 class="wp-block-heading">From Hands-On To Hands-Free</h2>
Nissan debuted its ProPilot system way back in 2016, which provided hands-on lane centering and distance-keeping assistance. In 2019, the company upgraded to a second-generation system, enabling limited hands-free driving on highways. Now, the collaboration with Wayve promises a massive leap forward in how vehicles interact with their environment.
The next-gen ProPilot system will be built around an adaptive AI developed by Wayve and will aim to provide drivers with a more intuitive, human-like experience behind the wheel. The new technology, which focuses on learning in a dynamic rather than static way, aims to provide greater adaptability in all kinds of real-world and unpredictable driving scenarios.
Wayve's approach is also distinct compared with many other players in the autonomous sector. Instead of locking into exclusive contracts with a single manufacturer, the flexible partnership model Wayve implemented allows it to operate across the automotive industry as a whole. This way, the company has positioned itself as a leader in scalable AI solutions for new electric vehicles and things beyond.
See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.
<h2 class="wp-block-heading">How Nissan And Wayve Are Shaping The Next Era Of Driving</h2>
Nissan's collaboration with Wayve signals an increasingly self-assured embrace of AI-driven, human-like-patterned autonomy behind the wheel. This is a concept that might reinvent the whole electric vehicle landscape on the eight- to 10-year horizon.
With the race toward full autonomy heating up, Nissan's decision to adopt Wayve's technology in its production vehicles has put the company on the frontline of a mobility revolution. With the support of some major investors and an established plan for flexible, human-like autonomy, Wayve is already on track to redefine the way the world drives.
Read Next:
<ul>
<li>BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>

MSFT

NVDA

UBER

Nissan Taps $1.3B-Backed AI Pioneer Wayve To Supercharge ProPilot System, Ushering A New Era Of Human-Like Driving

JP Morgan analyst Samik Chatterjee maintains HP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>) with a Overweight and lowers the price target from $40 to $29.

JP Morgan Maintains Overweight on HP, Lowers Price Target to $29

Stifel analyst Tore Svanberg maintains Alpha &amp; Omega (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AOSL#NASDAQ">AOSL</a>) with a Sell and lowers the price target from $30 to $18.

AOSL

Stifel Maintains Sell on Alpha & Omega, Lowers Price Target to $18

JP Morgan analyst Joseph Cardoso maintains Garmin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRMN#NYSE">GRMN</a>) with a Neutral and lowers the price target from $260 to $220.

GRMN

JP Morgan Maintains Neutral on Garmin, Lowers Price Target to $220

JP Morgan analyst Samik Chatterjee maintains Flex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLEX#NASDAQ">FLEX</a>) with a Overweight and lowers the price target from $52 to $40.

FLEX

JP Morgan Maintains Overweight on Flex, Lowers Price Target to $40

JP Morgan analyst Samik Chatterjee maintains Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) with a Neutral and lowers the price target from $265 to $220.

JP Morgan Maintains Neutral on Fabrinet, Lowers Price Target to $220

<a href="https://event.webcasts.com/starthere.jsp?ei=1711730&amp;tp_key=88606432f4">https://event.webcasts.com/starthere.jsp?ei=1711730&amp;tp_key=88606432f4</a>
&nbsp;

Guidance

Events

UnitedHealth Group CEO Reports Evidence Of Increase In Earlier Wellness Visits To Primary Care Physicians From Older Americans

Costco Wholesale Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/g44852132/costco-wholesale-corporation-announces-an-increase-in-its-quarterly-cash-dividend" rel="noreferrer noopener">increased its quarterly dividend</a> on Thursday, raising its regular cash payout from $1.16 to $1.30 per share. The proposed increment amounts to a 12% increase in the quarterly dividend.
The revised quarterly dividend will amount to $5.20 annually and is scheduled for distribution on May 16, 2025, to shareholders who hold Costco stock as of the close of business on May 2, 2025.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44850301/target-under-pressure-from-discretionary-spend-slowdown-mounting-inventory-risk-goldman-sachs-downgrades-stock" rel="noreferrer noopener">Target Under Pressure From Discretionary Spend Slowdown, Mounting Inventory Risk, Goldman Sachs Downgrades Stock</a>
Costco held <a target="_blank" href="https://d18rn0p25nwr6d.cloudfront.net/CIK-0000909832/53d4ecad-8de9-4252-8ef7-9cf31eb7ac5a.pdf" rel="noreferrer noopener">$12.4 billion in cash and equivalents</a> as of February 16, 2025. Last week, the retailer reported March <a target="_blank" href="https://www.benzinga.com/25/04/44745979/costco-wholesale-posts-strong-march-sales-uptick-in-purchases-ahead-of-tariffs-analysts-say" rel="noreferrer noopener">same-store sales growth</a> of 9.1%, with the U.S. comparable sales of 8.7%.
As of now, Costco operates 904 warehouse locations around the world. The bulk of its operations, 623 stores are based in the United States and Puerto Rico.
The remainder are spread across markets like Canada, Mexico, Japan, the United Kingdom, South Korea, Australia, and several other countries.
Beyond its physical locations, Costco&#8217;s online storefronts serve consumers in major markets such as the U.S., Canada, the U.K., Mexico, Korea, Taiwan, Japan, and Australia.
Costco is due to report third-quarter earnings on May 29.
<h2 class="wp-block-heading">Costco Wholesale Stock Prediction For 2025</h2>
Equity research analysts on and off Wall Street typically use earnings growth and fundamental research as a form of valuation and forecasting. But many in trading turn to technical analysis as a way to form predictive models for share price trajectory.
Some investors look to trends to help forecast where they believe a stock could trade at a certain point in the future. Looking at Costco Wholesale, an investor could make an assessment about a stock's long term prospects using a moving average and trend line. If they believe a stock will remain above the moving average, which many believe is a bullish signal, they can extrapolate that trend into the future using a trend line. For Costco Wholesale, the 200-day moving average sits at $924.32, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, which is below the current price of $967.75. For more on charts and trend lines, <a href="https://pro.benzinga.com/">see a description here.</a>
Traders believe that when a stock is above its moving average, it is a generally bullish signal, and when it crosses below, it is a more negative signal. Investors could use trend lines to make an educated guess about where a stock could trade at a later date if conditions remain stable.
Price Action: COST shares closed higher by 0.65% at $974 on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44850223/march-retail-sales-exceed-forecasts-says-analyst" target="_blank" rel="noreferrer noopener">March Retail Sales Exceed Forecasts, Analyst Notes Best-Performing Sectors</a></li>
</ul>
Photo by Steve Travelguide via Shutterstock

Dividends

General

COST

Retail Giant Costco Raises Dividend By 12%

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">195.95</td>
<td align="right">2.04</td>
<td align="right">1.05</td>
<td>115.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">80.47</td>
<td align="right">0.77</td>
<td align="right">0.96</td>
<td>42.8K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">185.84</td>
<td align="right">1.60</td>
<td align="right">0.86</td>
<td>4.7K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">90.17</td>
<td align="right">0.54</td>
<td align="right">0.60</td>
<td>554</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">125.27</td>
<td align="right">0.65</td>
<td align="right">0.52</td>
<td>18.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>)</td>
<td>Materials Select Sector SPDR</td>
<td align="right">80.51</td>
<td align="right">0.31</td>
<td align="right">0.38</td>
<td>6.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">39.97</td>
<td align="right">0.15</td>
<td align="right">0.37</td>
<td>505</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">46.67</td>
<td align="right">0.14</td>
<td align="right">0.30</td>
<td>354.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">77.10</td>
<td align="right">0.12</td>
<td align="right">0.15</td>
<td>2.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">80.27</td>
<td align="right">0.11</td>
<td align="right">0.13</td>
<td>1.7K</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">135</td>
<td align="right">-1.29</td>
<td align="right">-0.95</td>
<td>46.5K</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> this sector movers alerts can help traders understand macro-level market trends. Traders often look for sector movers to provide high-level analysis on which sectors are over- or under-performing to make better investing decisions on exchange traded funds (ETFs) or individual tickers in those sectors. 
For more information on sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

ETFs

XLRE

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For April 17, 2025

JP Morgan analyst Samik Chatterjee maintains F5 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) with a Neutral and lowers the price target from $296 to $285.

FFIV

JP Morgan Maintains Neutral on F5, Lowers Price Target to $285

Health Care

Press Releases

Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece

Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference

Helius Medical Technologies, Inc. Announces Exploration of Strategic Alternatives

Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS®) Device

Helius Announces First Portable Neuromodulation Stimulator (PoNS®) System Sale to the Veterans Affairs (VA) Healthcare System

Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target

Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market

Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study

Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device

Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface ("BCI") Technology Private Subsidiary

Comments

Helius Medical Tech

Noticias

Últimas noticias sobre Helius Medical Tech (NASDAQ:HSDT) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL